Ligand validation:6MOX

RET: RETINAL

RET is a Ligand Of Interest in 6MOX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MOX_RET_A_201	16%	58%	0.279	0.847	0.82	0.81	1	1	8	0	100%	1
4YKM_RET_A_201	78%	37%	0.084	0.927	0.71	1.75	-	6	6	0	100%	1
2G7B_RET_A_138	74%	34%	0.097	0.927	1.3	1.3	2	3	4	0	100%	0.8
6MOV_RET_A_201	74%	62%	0.091	0.919	0.78	0.68	1	-	6	0	100%	1
6NNX_RET_A_201	71%	60%	0.117	0.937	0.99	0.54	1	-	4	0	100%	1
4YFQ_RET_A_201	70%	39%	0.1	0.917	0.77	1.58	-	4	4	0	100%	1
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	8	0	100%	1
9F9J_RET_A_317	100%	71%	0.026	0.991	0.7	0.44	1	-	5	0	100%	1
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	1
7XJC_RET_A_301	100%	10%	0.028	0.992	1.93	2.43	2	14	2	0	100%	0.5
7XJD_RET_A_301	100%	10%	0.029	0.991	1.93	2.42	2	14	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.